Live Earnings Conference Call: Amylyx Pharmaceuticals will host a live Q2 2025 earnings call on August 7, 2025 at 8:00AM ET. Follow this link to get details and listen to Amylyx Pharmaceuticals' Q2 2025 earnings call when it goes live. Get details. Amylyx Pharmaceuticals (AMLX) Stock Chart & Stock Price History $8.19 +0.01 (+0.12%) Closing price 08/6/2025 04:00 PM EasternExtended Trading$8.28 +0.09 (+1.04%) As of 08/6/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Amylyx Pharmaceuticals Stock Price Performance The Amylyx Pharmaceuticals (AMLX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 335.64%, with a year-to-date return of 116.67%. In the past month, the stock has increased 21.15%, reflecting recent market activity. As of the latest close, Amylyx Pharmaceuticals traded at $8.19 with a market cap of $730.06 million and volume of 955,993 shares. Receive AMLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+6.09%1 Month Performance+21.15%3 Month Performance+68.69%Year-To-Date Performance+116.67%1 Year Performance+335.64% AMLX Stock Chart for Thursday, August, 7, 2025 AMLX Chart by TradingView Amylyx Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/06/2025$8.18$8.19+0.12%$8.27$7.98955,993 shs$730.06 million08/05/2025$7.96$8.18+2.76%$8.30$7.86855,056 shs$729.17 million08/04/2025$7.72$7.96+3.11%$8.12$7.56926,435 shs$709.55 million08/01/2025$8.03$7.72-3.86%$8.08$7.691.84 million shs$688.16 million07/31/2025$7.97$8.03+0.75%$8.29$7.841.16 million shs$715.79 million07/30/2025$7.95$7.97+0.25%$8.28$7.87980,550 shs$710.45 million07/29/2025$7.99$7.95-0.50%$8.10$7.84867,668 shs$708.66 million07/28/2025$8.15$7.99-1.96%$8.25$7.96695,488 shs$712.23 million07/25/2025$8.30$8.15-1.81%$8.30$8.061.07 million shs$726.49 million07/24/2025$8.39$8.30-1.07%$8.50$8.10682,846 shs$739.86 million Get the Latest News and Ratings for AMLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/23/2025$7.87$8.39+6.61%$8.67$7.701.85 million shs$747.89 million07/22/2025$8.21$7.87-4.14%$8.21$7.841.05 million shs$701.53 million07/21/2025$8.34$8.21-1.56%$8.72$8.141.87 million shs$731.84 million07/18/2025$8.28$8.34+0.72%$8.59$8.211.13 million shs$743.43 million07/17/2025$8.43$8.28-1.78%$8.50$8.071.32 million shs$738.09 million07/16/2025$8.12$8.43+3.82%$8.56$7.932.04 million shs$751.45 million07/15/2025$8.41$8.12-3.45%$8.41$7.882.00 million shs$723.83 million07/14/2025$7.68$8.41+9.51%$8.47$7.762.34 million shs$749.68 million07/11/2025$7.39$7.68+3.92%$7.73$7.211.68 million shs$684.60 million07/10/2025$7.24$7.39+2.07%$7.61$7.131.58 million shs$658.75 million07/09/2025$6.98$7.24+3.72%$7.40$6.902.00 million shs$645.37 million07/08/2025$6.76$6.98+3.25%$7.00$6.572.24 million shs$622.20 million07/07/2025$6.30$6.76+7.30%$7.00$6.142.32 million shs$602.59 million Related Companies Crinetics Pharmaceuticals Stock Chart NewAmsterdam Pharma Stock Chart Gemini Therapeutics Stock Chart Ultragenyx Pharmaceutical Stock Chart Organon & Co. Stock Chart Recursion Pharmaceuticals Stock Chart Amneal Pharmaceuticals Stock Chart Mirum Pharmaceuticals Stock Chart Bausch Health Cos Stock Chart Catalyst Pharmaceuticals Stock Chart Receive AMLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AMLX) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amylyx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amylyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AMLX Stock Alerts